Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Greg J. Kubicek"'
Autor:
Greg J. Kubicek, Sharif Ahmed
Publikováno v:
Journal of Clinical Oncology. 39:e13539-e13539
e13539 Background: Multi-disciplinary tumor boards (MTB) are a way to generate quality patient care by allowing different specialties to provide insight into patient care. While the vast majority of hospital systems have MTB there are several aspects
Autor:
Q. Xu, Ziad Boujaoude, Polina Khrizman, Christian Michael Squillante, Ashish Patel, Alexandre Hageboutros, Wissam Abouzgheib, Greg J. Kubicek
Publikováno v:
Journal of Clinical Oncology. 38:e21081-e21081
e21081 Background: The outcomes for locally advanced non-small cell lung cancer (NSCLC) are overall poor. This is a single arm phase 2 study (Clinical trials.gov NCT02568033) evaluating the role of stereotactic body radiosurgery (SBRT) along with ful
Publikováno v:
Journal of Clinical Oncology. 37:e13136-e13136
e13136 Background: Next Generation Sequencing (NGS) is increasingly used to identify actionable mutations for oncology treatment. We examined the results of NGS at our institution. Methods: We retrospectively reviewed the medical charts of 305 consec
Autor:
James Ohr, Steven A. Burton, John A. Vargo, Dwight E. Heron, Rodney E. Wegner, Robert L. Ferris, Ronny Kalash, Greg J. Kubicek, Jean-Claude M. Rwigema
Publikováno v:
Radiotherapy and Oncology. 104:91-95
Purpose Stereotactic body radiotherapy (SBRT) has emerged as a promising salvage strategy for unresectable, previously-irradiated recurrent squamous cell carcinomas of the head and neck (rSCCHN). Here-in, we report the first prospective evaluation of
Autor:
Patricia Gigliotti, James Ohr, Dwight E. Heron, Greg J. Kubicek, Steven A. Burton, Annette E. Quinn, Robert L. Ferris, Jean-Claude M. Rwigema, John A. Vargo, Rodney E. Wegner
Publikováno v:
Headneck. 34(8)
Background Stereotactic body radiotherapy (SBRT) has emerged as a promising salvage strategy for patients with recurrent, previously irradiated head and neck cancer; however, data are limited predominantly to squamous cell carcinomas. Herein, we repo
Autor:
Nati Lerman, Micheal Choi, Howard Warren Goldman, Piya V. Saraiya, Sucha O. Asbell, Anne Bexon, Greg J. Kubicek, Alan Turtz, Ashish Patel, Lesley Hughes, T LaCouture, Jinyu Xue
Publikováno v:
Journal of Clinical Oncology. 33:e20555-e20555
e20555 Background: Treatment for CNS metastatic disease for 1-4 metastatic lesions can include whole brain radiation (WBRT) or stereotactic radiosurgery (SRS).SRS in the setting of CNS 1-4 mets has...
Autor:
Athanassios Argiris, James Ohr, Greg J. Kubicek, Uma Duvvuri, Dwight Earl Heron, Athanasios Panayotis Kotsakis, Christina Spencer, Seungwon Kim, Jennifer R. Grandis, Jonas Talmadge Johnson, Julie E. Bauman, Michael K. Gibson, Robert L. Ferris
Publikováno v:
Journal of Clinical Oncology. 31:6043-6043
6043 Background: We previously developed a novel regimen by the addition of Pem to RT and E (Ann Oncol 2011;22:2482). The current study evaluated PemE in the phase II setting and assessed the addition of B, an anti-VEGF monoclonal antibody, to PemE b